APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Influenza A/B Nucleic Acid Detection Kit

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Influenza A/B Nucleic Acid Detection Kit Market Outlook and Growth Opportunities 2026

Report ID 17390988048 January 2026191 pages

Choose your research edition.

Industry ResearchInfluenza A/B Nucleic Acid Detection Kit Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza A/B Nucleic Acid Detection Kit Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Influenza A/B Nucleic Acid Detection Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza A/B Nucleic Acid Detection Kit Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza A/B Nucleic Acid Detection Kit Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Influenza A/B Nucleic Acid Detection Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Influenza A/B Nucleic Acid Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Influenza A/B Nucleic Acid Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Influenza A/B Nucleic Acid Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Influenza A/B Nucleic Acid Detection Kit market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Influenza A/B Nucleic Acid Detection Kit market include Certest Biotec, Diagnostica Longwood, MIZUHO MEDY, QIAGEN, DNA-Technology, FLASHTEST Technology, Xi'an Tianlong Science and Technology Co., Ltd, Shanghai ZJ Bio-Tech Co., Ltd. and Jiangsu Mole Bioscience Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Influenza A/B Nucleic Acid Detection Kit market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Influenza A/B Nucleic Acid Detection Kit and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Influenza A/B Nucleic Acid Detection Kit sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Influenza A/B Nucleic Acid Detection Kit market size, projected growth trends, production technologies, key applications, and end-use industries.

Influenza A/B Nucleic Acid Detection Kit Segment by Company

Certest Biotec

Diagnostica Longwood

MIZUHO MEDY

QIAGEN

DNA-Technology

FLASHTEST Technology

Xi'an Tianlong Science and Technology Co., Ltd

Shanghai ZJ Bio-Tech Co., Ltd.

Jiangsu Mole Bioscience Co., Ltd.

Coyote Bioscience Co., Ltd.

Zybio Inc.

Influenza A/B Nucleic Acid Detection Kit Segment by Type

32 Test/ Box

96 Test/ Box

Other Packaging Specifications

Influenza A/B Nucleic Acid Detection Kit Segment by Application

Hospital

CDC

Third-party Testing Agency

Influenza A/B Nucleic Acid Detection Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Influenza A/B Nucleic Acid Detection Kit status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Influenza A/B Nucleic Acid Detection Kit market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Influenza A/B Nucleic Acid Detection Kit significant trends, drivers, influence factors in global and regions.

6. To analyze Influenza A/B Nucleic Acid Detection Kit competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza A/B Nucleic Acid Detection Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza A/B Nucleic Acid Detection Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza A/B Nucleic Acid Detection Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Influenza A/B Nucleic Acid Detection Kit market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Influenza A/B Nucleic Acid Detection Kit industry.

Chapter 3: Detailed analysis of Influenza A/B Nucleic Acid Detection Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Influenza A/B Nucleic Acid Detection Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Influenza A/B Nucleic Acid Detection Kit in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Influenza A/B Nucleic Acid Detection Kit Industry Trends Table 2. Influenza A/B Nucleic Acid Detection Kit Industry Drivers Table 3. Influenza A/B Nucleic Acid Detection Kit Industry Opportunities and Challenges Table 4. Influenza A/B Nucleic Acid Detection Kit Industry Restraints Table 5. Global Influenza A/B Nucleic Acid Detection Kit Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Influenza A/B Nucleic Acid Detection Kit Revenue Share by Company (2021-2026) Table 7. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Company (k units) & (2021-2026) Table 8. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share by Company (2021-2026) Table 9. Global Influenza A/B Nucleic Acid Detection Kit Average Price (USD/unit) of Company (2021-2026) Table 10. Global Influenza A/B Nucleic Acid Detection Kit Company Ranking, (2024-2026) & (USD Million) Table 11. Global Influenza A/B Nucleic Acid Detection Kit Key Company Manufacturing Base & Headquarters Table 12. Global Influenza A/B Nucleic Acid Detection Kit Company, Product Type & Application Table 13. Global Influenza A/B Nucleic Acid Detection Kit Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Influenza A/B Nucleic Acid Detection Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 32 Test/ Box Table 18. Significant Companies of 96 Test/ Box Table 19. Significant Companies of Other Packaging Specifications Table 20. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Type (2021-2026) & (k units) Table 22. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Type (2027-2032) & (k units) Table 23. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share by Type (2021-2026) Table 24. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share by Type (2027-2032) Table 25. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type (2021-2026) Table 29. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of CDC Table 32. Significant Companies of Third-party Testing Agency Table 33. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Application (2021-2026) & (k units) Table 35. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Application (2027-2032) & (k units) Table 36. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share by Application (2021-2026) Table 37. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share by Application (2027-2032) Table 38. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application (2021-2026) Table 42. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application (2027-2032) Table 43. Global Influenza A/B Nucleic Acid Detection Kit Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Influenza A/B Nucleic Acid Detection Kit Sales by Region (2021-2026) & (k units) Table 45. Global Influenza A/B Nucleic Acid Detection Kit Sales Market Share by Region (2021-2026) Table 46. Global Influenza A/B Nucleic Acid Detection Kit Sales by Region (2027-2032) & (k units) Table 47. Global Influenza A/B Nucleic Acid Detection Kit Sales Market Share by Region (2027-2032) Table 48. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Region (2021-2026) Table 51. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Region (2027-2032) Table 53. Global Influenza A/B Nucleic Acid Detection Kit Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Influenza A/B Nucleic Acid Detection Kit Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Influenza A/B Nucleic Acid Detection Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Influenza A/B Nucleic Acid Detection Kit Sales by Country (2021-2026) & (k units) Table 58. Global Influenza A/B Nucleic Acid Detection Kit Sales Market Share by Country (2021-2026) Table 59. Global Influenza A/B Nucleic Acid Detection Kit Sales by Country (2027-2032) & (k units) Table 60. Global Influenza A/B Nucleic Acid Detection Kit Sales Market Share by Country (2027-2032) Table 61. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Market Share by Country (2021-2026) Table 63. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Market Share by Country (2027-2032) Table 65. Certest Biotec Company Information Table 66. Certest Biotec Business Overview Table 67. Certest Biotec Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Certest Biotec Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 69. Certest Biotec Recent Development Table 70. Diagnostica Longwood Company Information Table 71. Diagnostica Longwood Business Overview Table 72. Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 74. Diagnostica Longwood Recent Development Table 75. MIZUHO MEDY Company Information Table 76. MIZUHO MEDY Business Overview Table 77. MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 79. MIZUHO MEDY Recent Development Table 80. QIAGEN Company Information Table 81. QIAGEN Business Overview Table 82. QIAGEN Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. QIAGEN Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 84. QIAGEN Recent Development Table 85. DNA-Technology Company Information Table 86. DNA-Technology Business Overview Table 87. DNA-Technology Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. DNA-Technology Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 89. DNA-Technology Recent Development Table 90. FLASHTEST Technology Company Information Table 91. FLASHTEST Technology Business Overview Table 92. FLASHTEST Technology Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. FLASHTEST Technology Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 94. FLASHTEST Technology Recent Development Table 95. Xi'an Tianlong Science and Technology Co., Ltd Company Information Table 96. Xi'an Tianlong Science and Technology Co., Ltd Business Overview Table 97. Xi'an Tianlong Science and Technology Co., Ltd Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Xi'an Tianlong Science and Technology Co., Ltd Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 99. Xi'an Tianlong Science and Technology Co., Ltd Recent Development Table 100. Shanghai ZJ Bio-Tech Co., Ltd. Company Information Table 101. Shanghai ZJ Bio-Tech Co., Ltd. Business Overview Table 102. Shanghai ZJ Bio-Tech Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Shanghai ZJ Bio-Tech Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 104. Shanghai ZJ Bio-Tech Co., Ltd. Recent Development Table 105. Jiangsu Mole Bioscience Co., Ltd. Company Information Table 106. Jiangsu Mole Bioscience Co., Ltd. Business Overview Table 107. Jiangsu Mole Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Jiangsu Mole Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 109. Jiangsu Mole Bioscience Co., Ltd. Recent Development Table 110. Coyote Bioscience Co., Ltd. Company Information Table 111. Coyote Bioscience Co., Ltd. Business Overview Table 112. Coyote Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Coyote Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 114. Coyote Bioscience Co., Ltd. Recent Development Table 115. Zybio Inc. Company Information Table 116. Zybio Inc. Business Overview Table 117. Zybio Inc. Influenza A/B Nucleic Acid Detection Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Zybio Inc. Influenza A/B Nucleic Acid Detection Kit Product Portfolio Table 119. Zybio Inc. Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Influenza A/B Nucleic Acid Detection Kit Distributors List Table 123. Influenza A/B Nucleic Acid Detection Kit Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Influenza A/B Nucleic Acid Detection Kit Product Image Figure 2. Global Influenza A/B Nucleic Acid Detection Kit Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 4. Global Influenza A/B Nucleic Acid Detection Kit Sales (2021-2032) & (k units) Figure 5. Global Influenza A/B Nucleic Acid Detection Kit Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Influenza A/B Nucleic Acid Detection Kit Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 32 Test/ Box Image Figure 10. 96 Test/ Box Image Figure 11. Other Packaging Specifications Image Figure 12. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share by Type (2021-2032) Figure 15. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. CDC Image Figure 20. Third-party Testing Agency Image Figure 21. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share by Application (2021-2032) Figure 24. Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application (2021-2032) Figure 27. Global Influenza A/B Nucleic Acid Detection Kit Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Influenza A/B Nucleic Acid Detection Kit Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 32. North America Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 38. South America Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Influenza A/B Nucleic Acid Detection Kit Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Influenza A/B Nucleic Acid Detection Kit Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 32 Test/ Box
  • 96 Test/ Box
  • Other Packaging Specifications
Applications
  • Hospital
  • CDC
  • Third-party Testing Agency
Companies covered
  • Certest Biotec
  • Diagnostica Longwood
  • MIZUHO MEDY
  • QIAGEN
  • DNA-Technology
  • FLASHTEST Technology
  • Xi'an Tianlong Science and Technology Co., Ltd
  • Shanghai ZJ Bio-Tech Co., Ltd.
  • Jiangsu Mole Bioscience Co., Ltd.
  • Coyote Bioscience Co., Ltd.
  • Zybio Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032)
  4. 1.2.2 Global Influenza A/B Nucleic Acid Detection Kit Sales Volume (2021-2032)
  5. 1.2.3 Global Influenza A/B Nucleic Acid Detection Kit Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Influenza A/B Nucleic Acid Detection Kit Market Dynamics
  1. 2.1 Influenza A/B Nucleic Acid Detection Kit Industry Trends
  2. 2.2 Influenza A/B Nucleic Acid Detection Kit Industry Drivers
  3. 2.3 Influenza A/B Nucleic Acid Detection Kit Industry Opportunities and Challenges
  4. 2.4 Influenza A/B Nucleic Acid Detection Kit Industry Restraints
3 Influenza A/B Nucleic Acid Detection Kit Market by Company
  1. 3.1 Global Influenza A/B Nucleic Acid Detection Kit Company Revenue Ranking in 2025
  2. 3.2 Global Influenza A/B Nucleic Acid Detection Kit Revenue by Company (2021-2026)
  3. 3.3 Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Company (2021-2026)
  4. 3.4 Global Influenza A/B Nucleic Acid Detection Kit Average Price by Company (2021-2026)
  5. 3.5 Global Influenza A/B Nucleic Acid Detection Kit Company Ranking (2024-2026)
  6. 3.6 Global Influenza A/B Nucleic Acid Detection Kit Company Manufacturing Base and Headquarters
  7. 3.7 Global Influenza A/B Nucleic Acid Detection Kit Company Product Type and Application
  8. 3.8 Global Influenza A/B Nucleic Acid Detection Kit Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Influenza A/B Nucleic Acid Detection Kit Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Influenza A/B Nucleic Acid Detection Kit Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Influenza A/B Nucleic Acid Detection Kit Market by Type
  1. 4.1 Influenza A/B Nucleic Acid Detection Kit Type Introduction
  2. 4.1.1 32 Test/ Box
  3. 4.1.2 96 Test/ Box
  4. 4.1.3 Other Packaging Specifications
  5. 4.2 Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Type
  6. 4.2.1 Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Type
  10. 4.3.1 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Type (2021-2032)
  12. 4.3.3 Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type (2021-2032)
5 Influenza A/B Nucleic Acid Detection Kit Market by Application
  1. 5.1 Influenza A/B Nucleic Acid Detection Kit Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 CDC
  4. 5.1.3 Third-party Testing Agency
  5. 5.2 Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Application
  6. 5.2.1 Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Influenza A/B Nucleic Acid Detection Kit Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Influenza A/B Nucleic Acid Detection Kit Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Application
  10. 5.3.1 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Application (2021-2032)
  12. 5.3.3 Global Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application (2021-2032)
6 Influenza A/B Nucleic Acid Detection Kit Regional Sales and Value Analysis
  1. 6.1 Global Influenza A/B Nucleic Acid Detection Kit Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Influenza A/B Nucleic Acid Detection Kit Sales by Region (2021-2032)
  3. 6.2.1 Global Influenza A/B Nucleic Acid Detection Kit Sales by Region: 2021-2026
  4. 6.2.2 Global Influenza A/B Nucleic Acid Detection Kit Sales by Region (2027-2032)
  5. 6.3 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Region (2021-2032)
  7. 6.4.1 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Region: 2021-2026
  8. 6.4.2 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Region (2027-2032)
  9. 6.5 Global Influenza A/B Nucleic Acid Detection Kit Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032)
  12. 6.6.2 North America Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032)
  15. 6.7.2 Europe Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032)
  21. 6.9.2 South America Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Influenza A/B Nucleic Acid Detection Kit Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Country, 2025 VS 2032
7 Influenza A/B Nucleic Acid Detection Kit Country-level Sales and Value Analysis
  1. 7.1 Global Influenza A/B Nucleic Acid Detection Kit Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Influenza A/B Nucleic Acid Detection Kit Sales by Country (2021-2032)
  4. 7.3.1 Global Influenza A/B Nucleic Acid Detection Kit Sales by Country (2021-2026)
  5. 7.3.2 Global Influenza A/B Nucleic Acid Detection Kit Sales by Country (2027-2032)
  6. 7.4 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Country (2021-2032)
  7. 7.4.1 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Country (2021-2026)
  8. 7.4.2 Global Influenza A/B Nucleic Acid Detection Kit Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Influenza A/B Nucleic Acid Detection Kit Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Influenza A/B Nucleic Acid Detection Kit Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Certest Biotec
  2. 8.1.1 Certest Biotec Company Information
  3. 8.1.2 Certest Biotec Business Overview
  4. 8.1.3 Certest Biotec Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Certest Biotec Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  6. 8.1.5 Certest Biotec Recent Developments
  7. 8.2 Diagnostica Longwood
  8. 8.2.1 Diagnostica Longwood Company Information
  9. 8.2.2 Diagnostica Longwood Business Overview
  10. 8.2.3 Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Diagnostica Longwood Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  12. 8.2.5 Diagnostica Longwood Recent Developments
  13. 8.3 MIZUHO MEDY
  14. 8.3.1 MIZUHO MEDY Company Information
  15. 8.3.2 MIZUHO MEDY Business Overview
  16. 8.3.3 MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 MIZUHO MEDY Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  18. 8.3.5 MIZUHO MEDY Recent Developments
  19. 8.4 QIAGEN
  20. 8.4.1 QIAGEN Company Information
  21. 8.4.2 QIAGEN Business Overview
  22. 8.4.3 QIAGEN Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 QIAGEN Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  24. 8.4.5 QIAGEN Recent Developments
  25. 8.5 DNA-Technology
  26. 8.5.1 DNA-Technology Company Information
  27. 8.5.2 DNA-Technology Business Overview
  28. 8.5.3 DNA-Technology Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DNA-Technology Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  30. 8.5.5 DNA-Technology Recent Developments
  31. 8.6 FLASHTEST Technology
  32. 8.6.1 FLASHTEST Technology Company Information
  33. 8.6.2 FLASHTEST Technology Business Overview
  34. 8.6.3 FLASHTEST Technology Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 FLASHTEST Technology Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  36. 8.6.5 FLASHTEST Technology Recent Developments
  37. 8.7 Xi'an Tianlong Science and Technology Co., Ltd
  38. 8.7.1 Xi'an Tianlong Science and Technology Co., Ltd Company Information
  39. 8.7.2 Xi'an Tianlong Science and Technology Co., Ltd Business Overview
  40. 8.7.3 Xi'an Tianlong Science and Technology Co., Ltd Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Xi'an Tianlong Science and Technology Co., Ltd Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  42. 8.7.5 Xi'an Tianlong Science and Technology Co., Ltd Recent Developments
  43. 8.8 Shanghai ZJ Bio-Tech Co., Ltd.
  44. 8.8.1 Shanghai ZJ Bio-Tech Co., Ltd. Company Information
  45. 8.8.2 Shanghai ZJ Bio-Tech Co., Ltd. Business Overview
  46. 8.8.3 Shanghai ZJ Bio-Tech Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai ZJ Bio-Tech Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  48. 8.8.5 Shanghai ZJ Bio-Tech Co., Ltd. Recent Developments
  49. 8.9 Jiangsu Mole Bioscience Co., Ltd.
  50. 8.9.1 Jiangsu Mole Bioscience Co., Ltd. Company Information
  51. 8.9.2 Jiangsu Mole Bioscience Co., Ltd. Business Overview
  52. 8.9.3 Jiangsu Mole Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu Mole Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  54. 8.9.5 Jiangsu Mole Bioscience Co., Ltd. Recent Developments
  55. 8.10 Coyote Bioscience Co., Ltd.
  56. 8.10.1 Coyote Bioscience Co., Ltd. Company Information
  57. 8.10.2 Coyote Bioscience Co., Ltd. Business Overview
  58. 8.10.3 Coyote Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Coyote Bioscience Co., Ltd. Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  60. 8.10.5 Coyote Bioscience Co., Ltd. Recent Developments
  61. 8.11 Zybio Inc.
  62. 8.11.1 Zybio Inc. Company Information
  63. 8.11.2 Zybio Inc. Business Overview
  64. 8.11.3 Zybio Inc. Influenza A/B Nucleic Acid Detection Kit Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Zybio Inc. Influenza A/B Nucleic Acid Detection Kit Product Portfolio
  66. 8.11.5 Zybio Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Influenza A/B Nucleic Acid Detection Kit Value Chain Analysis
  2. 9.1.1 Influenza A/B Nucleic Acid Detection Kit Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Influenza A/B Nucleic Acid Detection Kit Sales Mode & Process
  6. 9.2 Influenza A/B Nucleic Acid Detection Kit Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Influenza A/B Nucleic Acid Detection Kit Distributors
  9. 9.2.3 Influenza A/B Nucleic Acid Detection Kit Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst